FALLBERICHT ÜBER 45-WÖCHIGE SICHERHEITSDATEN VON FÜNF PATIENTEN NACH DER BEHANDLUNG MIT HYALURONSÄURE-FILLERN, BOTULINUM TOXIN UND POLY-L-MILCHSÄURE IN EINER EINZIGEN SITZUNG.

An aesthetic full-face treatment with three classes of injectables (neuromodulators, hyaluronic acid, and biostimulators) in one session is a desired therapy for some patients. While therapies using one or two classes of injectables in a single treatment session are relatively well established, safety data on a threefold combination therapy in a single session has yet to be described. Here, we present a case report with 45-week safety data for five patients who received threefold combination therapy. Although the results indicate no additional risk, clinical studies with a larger group of patients are required to make a solid statement. [ABSTRACT FROM AUTHOR]